BioCentury | Nov 13, 2020
Translation in Brief

Roche and Immune-Onc mAb data; plus Capricor’s exosome-based COVID-19 vaccine induces cellular immunity, and more

...to develop COVD-19. The team, led by Public Health England...
...College London Immune-Onc Therapeutics Inc. Capricor Therapeutics Inc. Johns Hopkins University Public Health England Oxford...
BioCentury | Jun 11, 2020
Product Development

Emerging COVID-19 serology tests aim for neutralizing antibodies

...performance specs similar to Siemens’ in their Information for Use (IFU) documents; independent studies by Public Health England...
BioCentury | May 20, 2020
Product Development

Roche, Abbott say sample collection differences hampered COVID-19 sensitivity in independent studies

...live at more than 20 sites around the U.S. came on the heels of a Public Health England...
...patients, and had a 95% confidence interval of 88.1-100% (see “Roche Unveils Test Specs” ). Public Health England’s...
...the discrepancy between Public Health England and Roche’s analyses to their different sample collection starting points: while Public Health England...
BioCentury | Apr 7, 2020
Politics, Policy & Law

U.K. biopharma COVID-19 fight gets closer to home with PM in ICU, death toll escalating

...speeding development of its diagnostic testing capabilities to supplement those available in the U.K. through Public Health England...
BioCentury | Jul 10, 2017
Distillery Therapeutics

Infectious disease

...k.miraz.rahman@kcl.ac.uk CONTACT: J. Mark Sutton, Public Health England, National Infections Service, Salisbury, U.K. email: mark.sutton@phe.gov.uk Claire Quang King's College London Public Health England DNA...
BioCentury | Aug 24, 2015
Company News

Public Health England cancer news

...people, manufactures leukemia drug Erwinase , an Erwinia chrysanthemi-derived L-asparaginase, and an anthrax vaccine . Public Health England...
BioCentury | Jan 12, 2015
Company News

Kymab, Public Health England, University of Westminster, Wellcome Trust, Wellcome Trust Sanger Institute infectious news

...Kymab to lead a consortium, which includes Wellcome Trust Sanger Institute, University of Westminster and Public Health England...
...to discover and develop human mAbs against different Ebola strains. Kymab Ltd. , Cambridge, U.K. Public Health England...
BioCentury | Dec 19, 2013
Translation in Brief

Translational tidbits

...Partnership to discover candidates against undisclosed new cancer targets selected by the university ImmunoGenes AG Public Health England...
BioCentury | Dec 16, 2013
Company News

Pacific Biosciences, Public Health England, The Wellcome Trust Sanger Institute genomics news

...The partners will complete the sequences of 3,000 bacterial genomic strains from Public Health England's National Collection of...
...a publicly available genetic sequence database. Pacific Biosciences of California Inc. (NASDAQ:PACB), Menlo Park, Calif. Public Health England...
BioCentury | Dec 9, 2013
Company News

ImmunoGenes, Public Health England deal

...ImmunoGenes partnered with U.K. government agency Public Health England (PHE) to discover and develop mAbs to detect and...
...difficile infections. The partners could not be reached for details. ImmunoGenes AG , Zug, Switzerland Public Health England...
Items per page:
1 - 10 of 10
BioCentury | Nov 13, 2020
Translation in Brief

Roche and Immune-Onc mAb data; plus Capricor’s exosome-based COVID-19 vaccine induces cellular immunity, and more

...to develop COVD-19. The team, led by Public Health England...
...College London Immune-Onc Therapeutics Inc. Capricor Therapeutics Inc. Johns Hopkins University Public Health England Oxford...
BioCentury | Jun 11, 2020
Product Development

Emerging COVID-19 serology tests aim for neutralizing antibodies

...performance specs similar to Siemens’ in their Information for Use (IFU) documents; independent studies by Public Health England...
BioCentury | May 20, 2020
Product Development

Roche, Abbott say sample collection differences hampered COVID-19 sensitivity in independent studies

...live at more than 20 sites around the U.S. came on the heels of a Public Health England...
...patients, and had a 95% confidence interval of 88.1-100% (see “Roche Unveils Test Specs” ). Public Health England’s...
...the discrepancy between Public Health England and Roche’s analyses to their different sample collection starting points: while Public Health England...
BioCentury | Apr 7, 2020
Politics, Policy & Law

U.K. biopharma COVID-19 fight gets closer to home with PM in ICU, death toll escalating

...speeding development of its diagnostic testing capabilities to supplement those available in the U.K. through Public Health England...
BioCentury | Jul 10, 2017
Distillery Therapeutics

Infectious disease

...k.miraz.rahman@kcl.ac.uk CONTACT: J. Mark Sutton, Public Health England, National Infections Service, Salisbury, U.K. email: mark.sutton@phe.gov.uk Claire Quang King's College London Public Health England DNA...
BioCentury | Aug 24, 2015
Company News

Public Health England cancer news

...people, manufactures leukemia drug Erwinase , an Erwinia chrysanthemi-derived L-asparaginase, and an anthrax vaccine . Public Health England...
BioCentury | Jan 12, 2015
Company News

Kymab, Public Health England, University of Westminster, Wellcome Trust, Wellcome Trust Sanger Institute infectious news

...Kymab to lead a consortium, which includes Wellcome Trust Sanger Institute, University of Westminster and Public Health England...
...to discover and develop human mAbs against different Ebola strains. Kymab Ltd. , Cambridge, U.K. Public Health England...
BioCentury | Dec 19, 2013
Translation in Brief

Translational tidbits

...Partnership to discover candidates against undisclosed new cancer targets selected by the university ImmunoGenes AG Public Health England...
BioCentury | Dec 16, 2013
Company News

Pacific Biosciences, Public Health England, The Wellcome Trust Sanger Institute genomics news

...The partners will complete the sequences of 3,000 bacterial genomic strains from Public Health England's National Collection of...
...a publicly available genetic sequence database. Pacific Biosciences of California Inc. (NASDAQ:PACB), Menlo Park, Calif. Public Health England...
BioCentury | Dec 9, 2013
Company News

ImmunoGenes, Public Health England deal

...ImmunoGenes partnered with U.K. government agency Public Health England (PHE) to discover and develop mAbs to detect and...
...difficile infections. The partners could not be reached for details. ImmunoGenes AG , Zug, Switzerland Public Health England...
Items per page:
1 - 10 of 10